Why EDS Patients May Be More Vulnerable to Long COVID
- zebrathemiddleaged
- 2 days ago
- 5 min read
For many people with Ehlers-Danlos syndrome, COVID infection does not feel like a short illness with a clean ending. It can act more like a stress test on systems that were already working hard: joints, blood vessels, nerves, digestion, sleep, pain regulation, and immune responses.
That does not mean every person with EDS will develop long COVID. It also does not mean EDS “causes” long COVID. The picture is more careful than that. Research suggests that people with hypermobility, dysautonomia, mast cell symptoms, and other overlapping conditions may face a higher risk of lingering symptoms after viral illness. Those overlaps matter.
Ehlers-Danlos syndrome is a group of connective tissue disorders. The most recognized signs are joint hypermobility, frequent sprains, soft or stretchy skin, easy bruising, and chronic pain. But connective tissue is not limited to the knees, shoulders, or skin.
It helps support blood vessels, the gut, the pelvic floor, airways, and many small structures throughout the body. When that support is weaker or more flexible than usual, the body may use extra muscle tension, inflammation, and nervous system compensation just to get through daily life.
That baseline strain can make recovery from infection harder.
Common EDS-related issues that may overlap with long COVID include:
Orthostatic intolerance
Feeling worse when standing, often with dizziness, racing heart, weakness, or nausea.
Chronic pain and fatigue
Pain can drain energy, and poor sleep can make both symptoms worse.
Digestive problems
Reflux, bloating, constipation, diarrhea, and nausea are common in many EDS patients.
Headaches and sensory sensitivity
Migraine, light sensitivity, and sound sensitivity may flare after illness.
Temperature and circulation changes
Some people report cold hands and feet, flushing, blood pooling, or sweating changes.
Long COVID can involve many of these same systems. That overlap can make symptoms harder to identify, treat, and validate.
Research is finding links between hypermobility and long COVID
Long COVID research is still developing, but several patterns are becoming clearer. Studies and patient registries have shown that long COVID often includes fatigue, post-exertional symptom flares, brain fog, shortness of breath, sleep disruption, palpitations, and autonomic symptoms.
Recent research has also started to examine joint hypermobility. A large UK-based analysis published in 2024 reported an association between generalized joint hypermobility and a greater likelihood of long COVID symptoms after infection. The study did not prove that hypermobility directly causes long COVID, but it raised an important question: are some flexible connective tissue bodies less resilient to the aftereffects of viral illness?
Clinicians who treat EDS, POTS, mast cell disorders, and long COVID have noticed the same clinical overlap. Many describe patients who had manageable EDS before COVID, then developed a much lower threshold for activity, more severe dizziness, new food reactions, stronger pain flares, or crushing fatigue after infection.
That does not make the illness “all EDS.” It may mean COVID can amplify vulnerabilities that were already present.
Connective tissue may shape how the body handles inflammation
COVID can trigger inflammation in blood vessels, nerves, muscles, and other tissues. In most people, that inflammatory response settles with time. In long COVID, symptoms may continue long after the acute infection.
For EDS patients, connective tissue differences may affect how this response feels in the body. For example, looser blood vessels can contribute to blood pooling and unstable blood pressure. If COVID affects vascular function or autonomic control, a person who already had mild orthostatic intolerance may suddenly develop more severe symptoms.
This can show up as:
A racing heart after standing or showering
Heavy limbs after mild exertion
Dizziness in grocery stores or warm rooms
Feeling “flu-like” after basic activity
Needing much longer recovery after appointments or errands
Some patients describe it as losing the small margin they once had. Before COVID, they could pace, brace, hydrate, and function. After COVID, the same tools may not be enough.
Immune responses may be more reactive in some EDS patients
EDS is not classified as an immune disorder, but many people with EDS report immune-related or allergy-like symptoms. Some also carry diagnoses such as mast cell activation syndrome, autoimmune disease, asthma, chronic urticaria, or frequent inflammatory flares.
Mast cells are immune cells involved in allergic reactions, inflammation, and tissue repair. When mast cells become overactive, people may experience flushing, itching, hives, swelling, wheezing, diarrhea, reflux, low blood pressure, or sudden reactions to foods, heat, stress, or medications.
COVID can irritate immune pathways. For someone with a history of mast cell symptoms, that may mean more reactivity after infection. Some patients report that previously safe foods, scents, temperatures, or exertion levels start triggering symptoms.
Experts in allergy, immunology, and autonomic medicine often stress a cautious point: not every EDS patient has mast cell activation, and not every long COVID symptom is immune-driven. Still, immune instability may be one reason some EDS patients have a harder time returning to baseline.
Dysautonomia may be the bridge between EDS and long COVID
One of the clearest overlaps is dysautonomia, a problem with the autonomic nervous system. This system helps regulate heart rate, blood pressure, digestion, sweating, temperature, and breathing patterns.
POTS, or postural orthostatic tachycardia syndrome, is a form of dysautonomia seen in many people with hypermobile EDS and hypermobility spectrum disorders. POTS has also been reported after COVID infection.
That shared pathway matters because dysautonomia can make ordinary recovery advice backfire. “Just exercise more” may worsen symptoms if the person has post-exertional malaise, unstable heart rate, or blood pooling. A safer plan often starts with pacing, fluids, salt when appropriate, compression garments, recumbent movement, and careful monitoring.
Medical guidance is essential, especially for people with heart, kidney, blood pressure, or medication concerns.
Personal experiences show the cost of being misunderstood
Many EDS patients say the hardest part is not only the symptoms. It is being doubted.
A person who already had chronic pain may be told their post-COVID fatigue is “just EDS.” Someone with a history of anxiety may have palpitations dismissed, even when standing clearly triggers them. A patient who can look well while sitting may struggle to explain why a shower or short walk causes a two-day crash.
Personal stories from EDS communities often share a similar pattern:
COVID infection seemed mild at first
Weeks later, fatigue, dizziness, pain, or brain fog worsened
Old EDS symptoms became more intense
New symptoms appeared, especially heart rate changes or food reactions
Recovery required slower pacing than expected
These stories are not a substitute for research, but they are valuable. They point to questions researchers and clinicians need to take seriously.
EDS patients with long COVID often need care that sees the whole pattern, not just one symptom at a time. Helpful support may include:
A clinician familiar with EDS, dysautonomia, or complex chronic illness
Screening for POTS or orthostatic intolerance when symptoms fit
Evaluation of breathing, sleep, pain, migraine, and gastrointestinal symptoms
Careful pacing to avoid post-exertional crashes
Physical therapy that respects hypermobility and avoids overloading joints
Nutrition support when nausea, reflux, or food reactions limit intake
Documentation for school, work, disability accommodations, or caregiving needs
The goal is not to push the body back to its old pace by force. The goal is to reduce flares, protect joints, stabilize the nervous system, and rebuild capacity slowly when possible.
Why EDS Patients May Be More Vulnerable to Long COVID comes down to overlap and load. Connective tissue differences may affect blood flow and support. Dysautonomia may make standing and exertion harder. Immune reactivity may increase flares. Chronic pain and fatigue may leave less reserve after infection.
Research has not answered every question yet. Still, the pattern is strong enough to deserve attention.
For patients, the message is simple: symptoms are real, and worsening after COVID deserves care. For clinicians and families, the next step is to listen closely, look for treatable patterns, and avoid reducing complex illness to stress or deconditioning alone.
Comments